Lv31
250 积分 2025-10-11 加入
Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors
13小时前
待确认
Potent Cyclic Peptide Inhibitors Disrupt the FANCM–RMI Interaction
2天前
已完结
Cyclic Peptide Screening Methods for Preclinical Drug Discovery
2天前
已完结
Development of Second-Generation Phenoxyethylpiperidines as Potent Sigma-1 Receptor Agonists with Neuroprotective Potential for Alzheimer’s Disease
3天前
已完结
Overcoming Proteolytic Instability in a β-Turn Antimicrobial Peptide via Cyclization and Stereochemical Inversion to Combat MDR Bacteria
3天前
已完结
From Lead to Clinical Candidate: Discovery of BMS-986331 as a Potent and Selective N -Formyl Peptide Receptor 2 Agonist
3天前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
3天前
已完结
The coming of age of cyclic peptide drugs: an update on discovery technologies
25天前
已完结
Cyclic Peptides for Drug Development
25天前
已完结
Proline Analogues
27天前
已完结
皖公网安备34019202002308
